Lori Solomon is a writer at various publications including HealthDay News and United Press International. Based in Atlanta, she specializes in health policy, public health, and medicine, covering a range of topics such as mental health care, nutrition, and fitness. Her work has been featured in outlets like the Lincoln Journal Star and Medical Xpress.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Lori's articles predominantly focus on health-related topics, with a strong emphasis on citing data and scientific research. She would likely be interested in receiving pitches from experts who can provide insights or commentary based on robust data and evidence within the healthcare, medical research, children’s health, mental health, exercise or environmental health fields.
Given Lori's reliance on data-driven content and press releases as part of her coverage attributes, she may prefer sources that can offer access to new research findings or studies related to these areas. Additionally, professionals with expertise in public health policy or those involved in groundbreaking scientific discoveries could capture her attention.
It is important for potential contributors to note that Lori does not have a specified geographic focus but instead seems to cover global developments within the realm of healthcare and medical research.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Findings seen in adults with idiopathic sudden sensorineural hearing loss
Authors call for integrating routine audiometric screening into standard diabetes care
In adults and children, vitamin A linked to better lung function
However, chronic kidney disease is increasingly associated with diabetes and heart failure
By: Farrokh Sohrabi, Lori Solomon
TUESDAY, July 14, 2026 (HealthDay News) -- Among adults with insulin-treated diabetes, initiation of continuous glucose monitoring (CGM) by primary care clinici
By: Farrokh Sohrabi, Lori Solomon
TUESDAY, July 14, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has approved an expanded indication for Zoryve (roflumilast) cream 0.3 percent
By: Lori Solomon, Farrokh Sohrabi
WEDNESDAY, July 15, 2026 (HealthDay News) -- Obesity prevalence has risen substantially since 1999 and now affects more than 40 percent of U.S. adults and 20 pe
WEDNESDAY, July 15, 2026 (HealthDay News) -- Patients with irritable behaviors adversely influence emergency physicians' emotions, according to a study publishe
No clinically significant risks seen across range of neonatal morbidity and mortality outcomes
Review shows potential benefits include lower risks for death and sepsis
.jpg?w=480&auto=format%2Ccompress&fit=max)
